Compared with previous studies that examined the effects of DPP-4 inhibitors administered once per day on vascular endothelial functions, patients in this study had a longer duration of DM, and thus, potentially more advanced arteriosclerosis. This evidence concerns the gene DPP4 and diabetes mellitus.